IN8bio Inc (NASDAQ:INAB) has a beta value of -0.07 and has seen 1.04 million shares traded in the recent trading session. The company, currently valued at $16.37M, closed the recent trade at $0.34 per share which meant it gained $0.05 on the day or 19.55% during that session. The INAB stock price is -629.41% off its 52-week high price of $2.48 and 35.29% above the 52-week low of $0.22. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.94 million shares traded. The 3-month trading volume is 917.64K shares.
The consensus among analysts is that IN8bio Inc (INAB) is Buy stock at the moment, with a recommendation rating of 2.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -0.16.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
IN8bio Inc (NASDAQ:INAB) trade information
Sporting 19.55% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the INAB stock price touched $0.34 or saw a fall of -0.65%. Year-to-date, IN8bio Inc shares have moved -75.19%, while the 5-day performance has seen it change 13.79%. Over the past 30 days, the shares of IN8bio Inc (NASDAQ:INAB) have changed 30.04%. Short interest in the company has seen 0.15 million shares shorted with days to cover at 0.42.
IN8bio Inc (INAB) estimates and forecasts
Figures show that IN8bio Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -65.69% over the past 6 months, with this year growth rate of 48.00%, compared to 17.50% for the industry. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -50.62% over the past 5 years.
INAB Dividends
IN8bio Inc is expected to release its next earnings report on 2024-Aug-08 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
IN8bio Inc (NASDAQ:INAB)’s Major holders
Insiders own 21.56% of the company shares, while shares held by institutions stand at 49.62% with a share float percentage of 63.26%. Investors are also buoyed by the number of investors in a company, with IN8bio Inc having a total of 29.0 institutions that hold shares in the company. The top two institutional holders are AIGH CAPITAL MANAGEMENT LLC with over 2.13 million shares worth more than $1.8 million. As of 2024-06-30, AIGH CAPITAL MANAGEMENT LLC held 4.9157% of shares outstanding.
The other major institutional holder is VANGUARD GROUP INC, with the holding of over 1.42 million shares as of 2024-06-30. The firm’s total holdings are worth over $1.21 million and represent 3.2892% of shares outstanding.
